BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23864803)

  • 1. The start of chemotherapy until the end of radiotherapy in patients with limited-stage small cell lung cancer.
    Lee KJ; Lee EJ; Hur GY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH; Lee SY
    Korean J Intern Med; 2013 Jul; 28(4):449-55. PubMed ID: 23864803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the SER treatment period and prognosis of patients with small cell lung cancer.
    Xiao XG; Wang SJ; Hu LY; Chu Q; Wei Y; Li Y; Mei Q; Chen Y
    Asian Pac J Cancer Prev; 2014; 15(15):6415-9. PubMed ID: 25124635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thoracic radiotherapy timing and duration on progression-free survival in limited-stage small cell lung cancer.
    Zhao S; Zhou T; Ma S; Zhao Y; Zhan J; Fang W; Yang Y; Hou X; Zhang Z; Chen G; Zhang Y; Huang Y; Zhang L
    Cancer Med; 2018 Sep; 7(9):4208-4216. PubMed ID: 30019533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of surgery combined with chemoradiotherapy in treating limited-stage small cell lung cancer and prognosis analysis.
    Gu W; Zhong XLXLY
    J BUON; 2021; 26(3):812-818. PubMed ID: 34268940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of limited-stage small cell lung cancer with comprehensive treatment including radical resection.
    Zhong L; Suo J; Wang Y; Han J; Zhou H; Wei H; Zhu J
    World J Surg Oncol; 2020 Feb; 18(1):27. PubMed ID: 32013993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for the CONVERT trial-Concurrent ONce-daily VErsus twice-daily RadioTherapy: an international 2-arm randomised controlled trial of concurrent chemoradiotherapy comparing twice-daily and once-daily radiotherapy schedules in patients with limited stage small cell lung cancer (LS-SCLC) and good performance status.
    Faivre-Finn C; Falk S; Ashcroft L; Bewley M; Lorigan P; Wilson E; Groom N; Snee M; Fournel P; Cardenal F; Bezjak A; Blackhall F
    BMJ Open; 2016 Jan; 6(1):e009849. PubMed ID: 26792218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer.
    Zhang J; Fan M; Liu D; Zhao KL; Wu KL; Zhao WX; Zhu ZF; Fu XL
    Radiat Oncol; 2017 Mar; 12(1):51. PubMed ID: 28283034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of time of radio-chemotherapy and other therapeutic factors on treatment results in patients with limited disease small cell lung cancer.
    Sas-Korczynska B; Sokolowski A; Korzeniowski S
    Lung Cancer; 2013 Jan; 79(1):14-9. PubMed ID: 23153659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities.
    Kobayashi H; Wakuda K; Naito T; Mamesaya N; Omori S; Ono A; Kenmotsu H; Murakami H; Endo M; Harada H; Gon Y; Takahashi T
    Radiat Oncol; 2021 Mar; 16(1):52. PubMed ID: 33731123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.
    Kim HC; Song JS; Lee JC; Lee DH; Kim SW; Lee JS; Kim WS; Rho JK; Kim SY; Choi CM
    Int J Clin Exp Pathol; 2014; 7(10):6743-51. PubMed ID: 25400754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of risk factors for pulmonary complications in patients with limited-stage small cell lung cancer : A single-centre retrospective study.
    Sas-Korczyńska B; Łuczyńska E; Kamzol W; Sokołowski A
    Strahlenther Onkol; 2017 Feb; 193(2):141-149. PubMed ID: 27785518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation.
    Rutter CE; Park HS; Corso CD; Yeboa DN; Mancini BR; Lester-Coll NH; Kim AW; Decker RH
    Lung Cancer; 2015 Nov; 90(2):243-8. PubMed ID: 26277031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic evaluation of nutritional indicators in patients with limited-stage small cell lung cancer].
    Zhang JQ; Wang YY; Xu KP; Qi J; Wang X; Xu LM; Liu NN; Zhao LJ; Wang P
    Zhonghua Zhong Liu Za Zhi; 2019 Dec; 41(12):937-942. PubMed ID: 31874552
    [No Abstract]   [Full Text] [Related]  

  • 14. Is neoadjuvant chemotherapy mandatory for limited-disease small-cell lung cancer?
    Xu YJ; Zheng H; Gao W; Jiang GN; Xie HK; Chen C; Fei K
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):887-93. PubMed ID: 25156899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated With Treatment Refusal and Impact of Treatment Refusal on Survival of Patients With Small Cell Lung Cancer.
    Deviany PE; Ganti AK; Islam KMM
    Oncology (Williston Park); 2021 Mar; 35(3):111-118. PubMed ID: 33818051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Thoracic Radiotherapy Timing and Fractionation on Survival in Nonmetastatic Small Cell Lung Carcinoma.
    Wong AT; Rineer J; Schwartz D; Becker D; Safdieh J; Osborn V; Schreiber D
    Clin Lung Cancer; 2017 Mar; 18(2):207-212. PubMed ID: 27686970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic body radiotherapy with concurrent chemotherapy extends survival of patients with limited stage small cell lung cancer: a single-center prospective phase II study.
    Li C; Xiong Y; Zhou Z; Peng Y; Huang H; Xu M; Kang H; Peng B; Wang D; Yang X
    Med Oncol; 2014 Dec; 31(12):369. PubMed ID: 25416052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Concurrent Chemoradiotherapy with Original Chemotherapy Regimens may not be Suitable for Patients Who Failed to Respond to Induction Chemotherapy
in Limited-stage Small Cell Lung Cancer].
    Wang D; Xu L; Zhao L; Zhang W; Pang Q; Liu N; Chen X; Chen X; Yuan Z; Wang P
    Zhongguo Fei Ai Za Zhi; 2016 Dec; 19(12):871-878. PubMed ID: 27978874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of pulmonary resection in the diagnosis and treatment of limited-stage small cell lung cancer: revision of clinical diagnosis based on findings of resected specimen and its influence on survival.
    Iwata T; Nishiyama N; Nagano K; Izumi N; Mizuguchi S; Tsukioka T; Morita R; Chung K; Hanada S; Inoue K
    Gen Thorac Cardiovasc Surg; 2012 Jan; 60(1):43-52. PubMed ID: 22237738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. External Validation of a Survival Score for Limited-Stage Small Cell Lung Cancer Patients Treated with Chemoradiotherapy.
    Käsmann L; Abdo R; Eze C; Dantes M; Taugner J; Gennen K; Roengvoraphoj O; Rades D; Belka C; Manapov F
    Lung; 2020 Feb; 198(1):201-206. PubMed ID: 31897594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.